Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.

van Loben Sels JM, Green KY.

Viruses. 2019 May 10;11(5). pii: E432. doi: 10.3390/v11050432. Review.

2.

Sequential Gastroenteritis Outbreaks in a Single Year Caused by Norovirus Genotypes GII.2 and GII.6 in an Institutional Setting.

Karangwa CK, Parra GI, Bok K, Johnson JA, Levenson EA, Green KY.

Open Forum Infect Dis. 2017 Oct 23;4(4):ofx236. doi: 10.1093/ofid/ofx236. eCollection 2017 Fall.

3.

Vesicle-Cloaked Virus Clusters Are Optimal Units for Inter-organismal Viral Transmission.

Santiana M, Ghosh S, Ho BA, Rajasekaran V, Du WL, Mutsafi Y, De Jésus-Diaz DA, Sosnovtsev SV, Levenson EA, Parra GI, Takvorian PM, Cali A, Bleck C, Vlasova AN, Saif LJ, Patton JT, Lopalco P, Corcelli A, Green KY, Altan-Bonnet N.

Cell Host Microbe. 2018 Aug 8;24(2):208-220.e8. doi: 10.1016/j.chom.2018.07.006.

PMID:
30092198
4.

Norovirus, astrovirus, and sapovirus among immunocompromised patients at a tertiary care research hospital.

Daniel-Wayman S, Fahle G, Palmore T, Green KY, Prevots DR.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):143-146. doi: 10.1016/j.diagmicrobio.2018.05.017. Epub 2018 May 29.

PMID:
29934072
5.

Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection.

Levenson EA, Martens C, Kanakabandi K, Turner CV, Virtaneva K, Paneru M, Ricklefs S, Sosnovtsev SV, Johnson JA, Porcella SF, Green KY.

J Immunol. 2018 Jun 15;200(12):4157-4169. doi: 10.4049/jimmunol.1700384. Epub 2018 May 7.

6.

Norovirus surveillance comes of age: the impact of NoroNet.

Green KY.

Lancet Infect Dis. 2018 May;18(5):482-483. doi: 10.1016/S1473-3099(18)30062-8. Epub 2018 Jan 26. No abstract available.

PMID:
29396003
7.

A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies.

Tin CM, Yuan L, Dexter RJ, Parra GI, Bui T, Green KY, Sosnovtsev SV.

J Virol Methods. 2017 Oct;248:116-129. doi: 10.1016/j.jviromet.2017.06.017. Epub 2017 Jul 1.

8.

Seroprevalence for norovirus genogroup II, IV and VI in dogs.

Di Martino B, Di Profio F, Melegari I, Sarchese V, Massirio I, Palermo G, Romito G, Lorusso E, Lanave G, Bodnar L, Buonavoglia C, Marsilio F, Green KY, Martella V.

Vet Microbiol. 2017 May;203:68-72. doi: 10.1016/j.vetmic.2017.03.006. Epub 2017 Mar 4.

PMID:
28619170
9.

Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.

Sharma S, Carlsson B, Czakó R, Vene S, Haglund M, Ludvigsson J, Larson G, Hammarström L, Sosnovtsev SV, Atmar RL, Green KY, Estes MK, Svensson L.

J Virol. 2017 Jun 26;91(14). pii: e00567-17. doi: 10.1128/JVI.00567-17. Print 2017 Jul 15.

10.

A large outbreak of acute gastroenteritis in Shippensburg, Pennsylvania, 1972 revisited: evidence for common source exposure to a recombinant GII.Pg/GII.3 norovirus.

Johnson JA, Parra GI, Levenson EA, Green KY.

Epidemiol Infect. 2017 Jun;145(8):1591-1596. doi: 10.1017/S0950268817000498. Epub 2017 Mar 15.

PMID:
28294087
11.

Identification of Human Junctional Adhesion Molecule 1 as a Functional Receptor for the Hom-1 Calicivirus on Human Cells.

Sosnovtsev SV, Sandoval-Jaime C, Parra GI, Tin CM, Jones RW, Soden J, Barnes D, Freeth J, Smith AW, Green KY.

MBio. 2017 Feb 14;8(1). pii: e00031-17. doi: 10.1128/mBio.00031-17.

12.

Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.

Parra GI, Squires RB, Karangwa CK, Johnson JA, Lepore CJ, Sosnovtsev SV, Green KY.

PLoS Pathog. 2017 Jan 19;13(1):e1006136. doi: 10.1371/journal.ppat.1006136. eCollection 2017 Jan.

13.

The Norovirus NS3 Protein Is a Dynamic Lipid- and Microtubule-Associated Protein Involved in Viral RNA Replication.

Cotton BT, Hyde JL, Sarvestani ST, Sosnovtsev SV, Green KY, White PA, Mackenzie JM.

J Virol. 2017 Jan 18;91(3). pii: e02138-16. doi: 10.1128/JVI.02138-16. Print 2017 Feb 1.

14.

Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013.

Bok K, Prevots DR, Binder AM, Parra GI, Strollo S, Fahle GA, Behrle-Yardley A, Johnson JA, Levenson EA, Sosnovtsev SV, Holland SM, Palmore TN, Green KY.

Open Forum Infect Dis. 2016 Sep 8;3(3):ofw169. eCollection 2016 Sep.

15.

Mapping and modeling of a strain-specific epitope in the Norwalk virus capsid inner shell.

Parra GI, Sosnovtsev SV, Abente EJ, Sandoval-Jaime C, Bok K, Dolan MA, Green KY.

Virology. 2016 May;492:232-41. doi: 10.1016/j.virol.2016.02.019. Epub 2016 Mar 21.

16.

Editorial Commentary: Noroviruses and B Cells.

Green KY.

Clin Infect Dis. 2016 May 1;62(9):1139-40. doi: 10.1093/cid/ciw063. Epub 2016 Feb 11. No abstract available.

PMID:
26908783
17.

Nucleolin promotes in vitro translation of feline calicivirus genomic RNA.

Hernández BA, Sandoval-Jaime C, Sosnovtsev SV, Green KY, Gutiérrez-Escolano AL.

Virology. 2016 Feb;489:51-62. doi: 10.1016/j.virol.2015.12.001. Epub 2015 Dec 18.

18.

Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.

Garaicoechea L, Aguilar A, Parra GI, Bok M, Sosnovtsev SV, Canziani G, Green KY, Bok K, Parreño V.

PLoS One. 2015 Aug 12;10(8):e0133665. doi: 10.1371/journal.pone.0133665. eCollection 2015.

19.

Genome of Emerging Norovirus GII.17, United States, 2014.

Parra GI, Green KY.

Emerg Infect Dis. 2015 Aug;21(8):1477-9. doi: 10.3201/eid2108.150652.

20.

Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.

Kim SH, Chen S, Jiang X, Green KY, Samal SK.

Virology. 2015 Oct;484:163-9. doi: 10.1016/j.virol.2015.06.003. Epub 2015 Jun 20.

21.

Recovery of murine norovirus and feline calicivirus from plasmids encoding EMCV IRES in stable cell lines expressing T7 polymerase.

Sandoval-Jaime C, Green KY, Sosnovtsev SV.

J Virol Methods. 2015 Jun 1;217:1-7. doi: 10.1016/j.jviromet.2015.02.003. Epub 2015 Feb 16.

22.

Seroprevalence of norovirus genogroup IV antibodies among humans, Italy, 2010-2011.

Di Martino B, Di Profio F, Ceci C, Di Felice E, Green KY, Bok K, De Grazia S, Giammanco GM, Massirio I, Lorusso E, Buonavoglia C, Marsilio F, Martella V.

Emerg Infect Dis. 2014 Nov;20(11):1828-32. doi: 10.3201/eid2011.131601.

23.

In appreciation of Albert Z. Kapikian.

Green KY.

Clin Microbiol Infect. 2014 Aug;20(8):715. doi: 10.1111/1469-0691.12770. No abstract available.

24.

Norovirus infection in immunocompromised hosts.

Green KY.

Clin Microbiol Infect. 2014 Aug;20(8):717-23. doi: 10.1111/1469-0691.12761. Review.

25.

Advances in norovirus biology.

Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW.

Cell Host Microbe. 2014 Jun 11;15(6):668-80. doi: 10.1016/j.chom.2014.05.015. Review.

26.

Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice.

Kim SH, Chen S, Jiang X, Green KY, Samal SK.

J Virol. 2014 Sep 1;88(17):9718-27. doi: 10.1128/JVI.01570-14. Epub 2014 Jun 11.

27.

Sequential gastroenteritis episodes caused by 2 norovirus genotypes.

Parra GI, Green KY.

Emerg Infect Dis. 2014 Jun;20(6):1016-8. doi: 10.3201/eid2006.131627.

28.

Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Kaufman SS, Green KY, Korba BE.

Antiviral Res. 2014 May;105:80-91. doi: 10.1016/j.antiviral.2014.02.012. Epub 2014 Feb 25. Review.

29.

Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Mahar JE, Donker NC, Bok K, Talbo GH, Green KY, Kirkwood CD.

J Virol. 2014 Feb;88(4):1942-52. doi: 10.1128/JVI.02992-13. Epub 2013 Nov 27.

30.

Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995-1996).

Prikhodko VG, Sandoval-Jaime C, Abente EJ, Bok K, Parra GI, Rogozin IB, Ostlund EN, Green KY, Sosnovtsev SV.

Virus Genes. 2014 Feb;48(1):96-110. doi: 10.1007/s11262-013-1005-0. Epub 2013 Nov 12.

PMID:
24217871
31.

GIV Noroviruses in Wastewaters and in Stool Specimens from Hospitalized Patients.

Muscillo M, Fratini M, Graffeo R, Sanguinetti M, Martella V, Green KY, Della Libera S, La Rosa G.

Food Environ Virol. 2013 Aug 13. [Epub ahead of print]

32.

Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid.

Parra GI, Azure J, Fischer R, Bok K, Sandoval-Jaime C, Sosnovtsev SV, Sander P, Green KY.

PLoS One. 2013 Jun 21;8(6):e67592. doi: 10.1371/journal.pone.0067592. Print 2013.

33.

Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis.

Chen Z, Sosnovtsev SV, Bok K, Parra GI, Makiya M, Agulto L, Green KY, Purcell RH.

J Virol. 2013 Sep;87(17):9547-57. doi: 10.1128/JVI.01376-13. Epub 2013 Jun 19.

34.

Epidemiology and evolution of rotaviruses and noroviruses from an archival WHO Global Study in Children (1976-79) with implications for vaccine design.

Rackoff LA, Bok K, Green KY, Kapikian AZ.

PLoS One. 2013;8(3):e59394. doi: 10.1371/journal.pone.0059394. Epub 2013 Mar 25.

35.

Structures of the compact helical core domains of feline calicivirus and murine norovirus VPg proteins.

Leen EN, Kwok KY, Birtley JR, Simpson PJ, Subba-Reddy CV, Chaudhry Y, Sosnovtsev SV, Green KY, Prater SN, Tong M, Young JC, Chung LM, Marchant J, Roberts LO, Kao CC, Matthews S, Goodfellow IG, Curry S.

J Virol. 2013 May;87(10):5318-30. doi: 10.1128/JVI.03151-12. Epub 2013 Mar 13.

36.

Complete Genome Sequence of GII.4 Human Norovirus HS191.

Sosnovtsev SV, Bok K, Wang Q, Saif LJ, Green KY.

Genome Announc. 2013 Jan;1(1). pii: e00169-12. doi: 10.1128/genomeA.00169-12. Epub 2013 Feb 14.

37.

The importance of intergenic recombination in norovirus GII.3 evolution.

Mahar JE, Bok K, Green KY, Kirkwood CD.

J Virol. 2013 Apr;87(7):3687-98. doi: 10.1128/JVI.03056-12. Epub 2013 Jan 16.

38.

The feline calicivirus leader of the capsid protein is associated with cytopathic effect.

Abente EJ, Sosnovtsev SV, Sandoval-Jaime C, Parra GI, Bok K, Green KY.

J Virol. 2013 Mar;87(6):3003-17. doi: 10.1128/JVI.02480-12. Epub 2012 Dec 26.

39.

Genetic characterization of a reptilian calicivirus (Cro1).

Sandoval-Jaime C, Parra GI, Smith AW, Green KY, Sosnovtsev SV.

Virol J. 2012 Nov 29;9:297. doi: 10.1186/1743-422X-9-297.

40.

Norovirus gastroenteritis in immunocompromised patients.

Bok K, Green KY.

N Engl J Med. 2012 Nov 29;367(22):2126-32. doi: 10.1056/NEJMra1207742. Review. No abstract available.

41.

Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K, Green KY.

J Virol. 2012 Jul;86(13):7414-26. doi: 10.1128/JVI.06729-11. Epub 2012 Apr 24.

42.

Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma.

Hwang S, Maloney NS, Bruinsma MW, Goel G, Duan E, Zhang L, Shrestha B, Diamond MS, Dani A, Sosnovtsev SV, Green KY, Lopez-Otin C, Xavier RJ, Thackray LB, Virgin HW.

Cell Host Microbe. 2012 Apr 19;11(4):397-409. doi: 10.1016/j.chom.2012.03.002.

43.

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY.

Vaccine. 2012 May 21;30(24):3580-6. doi: 10.1016/j.vaccine.2012.03.050. Epub 2012 Mar 31.

44.

Diversity of murine norovirus strains isolated from asymptomatic mice of different genetic backgrounds within a single U.S. research institute.

Barron EL, Sosnovtsev SV, Bok K, Prikhodko V, Sandoval-Jaime C, Rhodes CR, Hasenkrug K, Carmody AB, Ward JM, Perdue K, Green KY.

PLoS One. 2011;6(6):e21435. doi: 10.1371/journal.pone.0021435. Epub 2011 Jun 28.

45.

Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period.

Boon D, Mahar JE, Abente EJ, Kirkwood CD, Purcell RH, Kapikian AZ, Green KY, Bok K.

J Virol. 2011 Sep;85(17):8656-66. doi: 10.1128/JVI.00472-11. Epub 2011 Jun 29.

46.

Chimpanzees as an animal model for human norovirus infection and vaccine development.

Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, Purcell RH, Green KY.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):325-30. doi: 10.1073/pnas.1014577107. Epub 2010 Dec 20.

47.

Polypyrimidine tract binding protein functions as a negative regulator of feline calicivirus translation.

Karakasiliotis I, Vashist S, Bailey D, Abente EJ, Green KY, Roberts LO, Sosnovtsev SV, Goodfellow IG.

PLoS One. 2010 Mar 10;5(3):e9562. doi: 10.1371/journal.pone.0009562.

48.

Visualization of feline calicivirus replication in real-time with recombinant viruses engineered to express fluorescent reporter proteins.

Abente EJ, Sosnovtsev SV, Bok K, Green KY.

Virology. 2010 Apr 25;400(1):18-31. doi: 10.1016/j.virol.2009.12.035. Epub 2010 Feb 4.

49.

Expression and self-assembly of virus-like particles from two genotypes of marine vesiviruses and development of an ELISA for the detection of antibodies.

McClenahan SD, Bok K, Sosnovtsev SV, Neill JD, Burek KA, Beckmen KB, Smith AW, Green KY, Romero CH.

Vet Microbiol. 2010 May 19;142(3-4):184-92. doi: 10.1016/j.vetmic.2009.09.057. Epub 2009 Oct 20.

50.

Evolutionary dynamics of GII.4 noroviruses over a 34-year period.

Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, Green KY.

J Virol. 2009 Nov;83(22):11890-901. doi: 10.1128/JVI.00864-09. Epub 2009 Sep 16.

Supplemental Content

Loading ...
Support Center